nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylnaltrexone—Buprenorphine—CYP2C18—chronic kidney failure	0.0308	0.206	CrCbGaD
Methylnaltrexone—Hydromorphone—PTGS1—chronic kidney failure	0.0148	0.0991	CrCbGaD
Methylnaltrexone—Buprenorphine—CYP2C19—chronic kidney failure	0.0138	0.0923	CrCbGaD
Methylnaltrexone—Oxymorphone—CYP3A4—chronic kidney failure	0.0119	0.0799	CrCbGaD
Methylnaltrexone—Hydrocodone—CYP3A4—chronic kidney failure	0.0104	0.0698	CrCbGaD
Methylnaltrexone—Naltrexone—ABCB1—chronic kidney failure	0.00993	0.0665	CrCbGaD
Methylnaltrexone—Oxycodone—CYP3A4—chronic kidney failure	0.00952	0.0637	CrCbGaD
Methylnaltrexone—Buprenorphine—CYP3A4—chronic kidney failure	0.00877	0.0587	CrCbGaD
Methylnaltrexone—Naloxone—CYP3A4—chronic kidney failure	0.0087	0.0583	CrCbGaD
Methylnaltrexone—Hydromorphone—CYP3A4—chronic kidney failure	0.00864	0.0578	CrCbGaD
Methylnaltrexone—Naloxone—ALB—chronic kidney failure	0.00759	0.0508	CrCbGaD
Methylnaltrexone—Buprenorphine—ABCB1—chronic kidney failure	0.0073	0.0489	CrCbGaD
Methylnaltrexone—Naloxone—ABCB1—chronic kidney failure	0.00725	0.0485	CrCbGaD
Methylnaltrexone—OPRK1—G alpha (i) signalling events—CCL5—chronic kidney failure	0.00304	0.00358	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—NPS—chronic kidney failure	0.003	0.00352	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Melatonin metabolism and effects—NFKB1—chronic kidney failure	0.00295	0.00347	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—NPY—chronic kidney failure	0.00295	0.00347	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—chronic kidney failure	0.00294	0.00345	CbGpPWpGaD
Methylnaltrexone—OPRM1—TCR Signaling Pathway—IL1B—chronic kidney failure	0.0029	0.0034	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—PTH—chronic kidney failure	0.00287	0.00338	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—CRH—chronic kidney failure	0.00285	0.00335	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—OXT—chronic kidney failure	0.00285	0.00335	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Biological oxidations—CYP2C18—chronic kidney failure	0.00282	0.00332	CbGpPWpGaD
Methylnaltrexone—OPRK1—Peptide ligand-binding receptors—F2—chronic kidney failure	0.00279	0.00328	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metapathway biotransformation—CYP2C18—chronic kidney failure	0.00278	0.00327	CbGpPWpGaD
Methylnaltrexone—OPRM1—Peptide ligand-binding receptors—CCR5—chronic kidney failure	0.00275	0.00323	CbGpPWpGaD
Methylnaltrexone—OPRK1—G alpha (i) signalling events—CCR5—chronic kidney failure	0.00274	0.00322	CbGpPWpGaD
Methylnaltrexone—OPRM1—TCR Signaling Pathway—NFKB1—chronic kidney failure	0.0027	0.00318	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—NPS—chronic kidney failure	0.0027	0.00317	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—DRD1—chronic kidney failure	0.00265	0.00311	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic kidney failure	0.00259	0.00305	CbGpPWpGaD
Methylnaltrexone—OPRM1—G alpha (i) signalling events—CCL5—chronic kidney failure	0.00257	0.00302	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—AVP—chronic kidney failure	0.00256	0.00301	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCRs, Class A Rhodopsin-like—CCR5—chronic kidney failure	0.00254	0.00299	CbGpPWpGaD
Methylnaltrexone—OPRK1—Peptide ligand-binding receptors—POMC—chronic kidney failure	0.00254	0.00299	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—NPY—chronic kidney failure	0.00249	0.00293	CbGpPWpGaD
Methylnaltrexone—OPRK1—Peptide ligand-binding receptors—CCL2—chronic kidney failure	0.00248	0.00292	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic kidney failure	0.00244	0.00287	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL5—chronic kidney failure	0.00242	0.00284	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—OXT—chronic kidney failure	0.00241	0.00283	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—CRH—chronic kidney failure	0.00241	0.00283	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—chronic kidney failure	0.00239	0.0028	CbGpPWpGaD
Methylnaltrexone—OPRM1—Peptide ligand-binding receptors—F2—chronic kidney failure	0.00236	0.00277	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Biological oxidations—CYP2C19—chronic kidney failure	0.00234	0.00275	CbGpPWpGaD
Methylnaltrexone—OPRM1—G alpha (i) signalling events—CCR5—chronic kidney failure	0.00232	0.00272	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metapathway biotransformation—CYP2C19—chronic kidney failure	0.00231	0.00271	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—NPS—chronic kidney failure	0.00228	0.00268	CbGpPWpGaD
Methylnaltrexone—OPRM1—TCR Signaling Pathway—TGFB1—chronic kidney failure	0.00225	0.00265	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—DRD1—chronic kidney failure	0.00224	0.00263	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—chronic kidney failure	0.00218	0.00256	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—AVP—chronic kidney failure	0.00217	0.00255	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—chronic kidney failure	0.00215	0.00253	CbGpPWpGaD
Methylnaltrexone—OPRM1—Peptide ligand-binding receptors—POMC—chronic kidney failure	0.00215	0.00252	CbGpPWpGaD
Methylnaltrexone—OPRK1—G alpha (i) signalling events—POMC—chronic kidney failure	0.00214	0.00252	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Biological oxidations—PTGS1—chronic kidney failure	0.00214	0.00251	CbGpPWpGaD
Methylnaltrexone—OPRM1—Peptide ligand-binding receptors—CCL2—chronic kidney failure	0.0021	0.00247	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—CRHR1—chronic kidney failure	0.0021	0.00247	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic kidney failure	0.00206	0.00242	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—chronic kidney failure	0.00204	0.0024	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—AVP—chronic kidney failure	0.00195	0.00229	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Phase 1 - Functionalization of compounds—POMC—chronic kidney failure	0.00193	0.00227	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—PTH—chronic kidney failure	0.00192	0.00226	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CRHR1—chronic kidney failure	0.00191	0.00224	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—F2—chronic kidney failure	0.00187	0.0022	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—EDN1—chronic kidney failure	0.00186	0.00218	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Biological oxidations—CYP3A4—chronic kidney failure	0.00185	0.00217	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—CCL5—chronic kidney failure	0.00184	0.00217	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—chronic kidney failure	0.00184	0.00217	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metapathway biotransformation—CYP3A4—chronic kidney failure	0.00182	0.00214	CbGpPWpGaD
Methylnaltrexone—OPRM1—G alpha (i) signalling events—POMC—chronic kidney failure	0.00181	0.00213	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—CRHR1—chronic kidney failure	0.00177	0.00209	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—PTH—chronic kidney failure	0.00174	0.00205	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—chronic kidney failure	0.0017	0.002	CbGpPWpGaD
Methylnaltrexone—OPRM1—TCR Signaling Pathway—IL6—chronic kidney failure	0.0017	0.00199	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—NPY—chronic kidney failure	0.00167	0.00196	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL2—chronic kidney failure	0.00167	0.00196	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—CCR5—chronic kidney failure	0.00166	0.00195	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—AVP—chronic kidney failure	0.00165	0.00194	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—PTH—chronic kidney failure	0.00162	0.00191	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CRHR1—chronic kidney failure	0.00161	0.00189	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—OXT—chronic kidney failure	0.00161	0.00189	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—CRH—chronic kidney failure	0.00161	0.00189	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—COL4A5—chronic kidney failure	0.0016	0.00188	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—F2—chronic kidney failure	0.00158	0.00186	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—EDN1—chronic kidney failure	0.00157	0.00184	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—CCL5—chronic kidney failure	0.00156	0.00183	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—NPS—chronic kidney failure	0.00153	0.00179	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—NPY—chronic kidney failure	0.00151	0.00178	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—DRD1—chronic kidney failure	0.0015	0.00176	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—TFDP2—chronic kidney failure	0.00149	0.00175	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—PTH—chronic kidney failure	0.00147	0.00173	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—OXT—chronic kidney failure	0.00146	0.00172	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CRH—chronic kidney failure	0.00146	0.00172	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PIP5K1B—chronic kidney failure	0.00145	0.00171	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—chronic kidney failure	0.00144	0.00169	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—F2—chronic kidney failure	0.00142	0.00167	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—NPY—chronic kidney failure	0.00141	0.00166	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—chronic kidney failure	0.00141	0.00166	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—CCR5—chronic kidney failure	0.0014	0.00165	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—NPS—chronic kidney failure	0.00139	0.00163	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Biological oxidations—CYP1A1—chronic kidney failure	0.00138	0.00162	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—OXT—chronic kidney failure	0.00136	0.0016	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—CRH—chronic kidney failure	0.00136	0.0016	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metapathway biotransformation—CYP1A1—chronic kidney failure	0.00136	0.0016	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—DRD1—chronic kidney failure	0.00136	0.0016	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—COL4A5—chronic kidney failure	0.00135	0.00159	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PGF—chronic kidney failure	0.00132	0.00156	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—POMC—chronic kidney failure	0.0013	0.00152	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—NPS—chronic kidney failure	0.00129	0.00152	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—NPY—chronic kidney failure	0.00128	0.00151	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—CCL2—chronic kidney failure	0.00127	0.00149	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—DRD1—chronic kidney failure	0.00126	0.00149	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—TFDP2—chronic kidney failure	0.00126	0.00148	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PRKAG2—chronic kidney failure	0.00125	0.00146	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—OXT—chronic kidney failure	0.00124	0.00145	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CRH—chronic kidney failure	0.00124	0.00145	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PIP5K1B—chronic kidney failure	0.00123	0.00145	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—F2—chronic kidney failure	0.0012	0.00141	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—COL4A3—chronic kidney failure	0.00118	0.00139	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—NPS—chronic kidney failure	0.00117	0.00138	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—HBEGF—chronic kidney failure	0.00116	0.00136	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—DRD1—chronic kidney failure	0.00115	0.00135	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CRHR1—chronic kidney failure	0.00113	0.00132	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PGF—chronic kidney failure	0.00112	0.00132	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—AVP—chronic kidney failure	0.0011	0.0013	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—POMC—chronic kidney failure	0.0011	0.00129	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—LRP2—chronic kidney failure	0.00108	0.00127	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—CCL2—chronic kidney failure	0.00107	0.00126	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PRKAG2—chronic kidney failure	0.00105	0.00124	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—EDN1—chronic kidney failure	0.00105	0.00123	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—CCL5—chronic kidney failure	0.00104	0.00122	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PTH—chronic kidney failure	0.00103	0.00121	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Biological oxidations—POMC—chronic kidney failure	0.00103	0.00121	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CYBB—chronic kidney failure	0.001	0.00118	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—AVP—chronic kidney failure	0.001	0.00118	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—COL4A3—chronic kidney failure	0.000998	0.00117	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—HBEGF—chronic kidney failure	0.000976	0.00115	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—FABP1—chronic kidney failure	0.000969	0.00114	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—EDN1—chronic kidney failure	0.000953	0.00112	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CRHR1—chronic kidney failure	0.000952	0.00112	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—FGF23—chronic kidney failure	0.000951	0.00112	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CCL5—chronic kidney failure	0.000945	0.00111	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—CCR5—chronic kidney failure	0.000938	0.0011	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—AVP—chronic kidney failure	0.000932	0.0011	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—AGXT—chronic kidney failure	0.000919	0.00108	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—GATM—chronic kidney failure	0.000919	0.00108	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—LRP2—chronic kidney failure	0.000913	0.00107	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—NPY—chronic kidney failure	0.000895	0.00105	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—EDN1—chronic kidney failure	0.000887	0.00104	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—CCL5—chronic kidney failure	0.00088	0.00103	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PTH—chronic kidney failure	0.000871	0.00102	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CRH—chronic kidney failure	0.000863	0.00101	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—OXT—chronic kidney failure	0.000863	0.00101	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CCR5—chronic kidney failure	0.000852	0.001	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CYBB—chronic kidney failure	0.000848	0.000997	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—AVP—chronic kidney failure	0.000846	0.000995	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ACAT1—chronic kidney failure	0.00084	0.000988	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—NCF1—chronic kidney failure	0.000827	0.000972	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—NPS—chronic kidney failure	0.000818	0.000962	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—EDN1—chronic kidney failure	0.000805	0.000947	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—F2—chronic kidney failure	0.000805	0.000946	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—FGF23—chronic kidney failure	0.000803	0.000945	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—DRD1—chronic kidney failure	0.000803	0.000944	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CCL5—chronic kidney failure	0.000799	0.000939	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—CCR5—chronic kidney failure	0.000793	0.000932	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—MLXIPL—chronic kidney failure	0.000781	0.000918	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CYBA—chronic kidney failure	0.000777	0.000914	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—NPY—chronic kidney failure	0.000756	0.000889	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—POMC—chronic kidney failure	0.000733	0.000862	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—F2—chronic kidney failure	0.000731	0.000859	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—OXT—chronic kidney failure	0.00073	0.000858	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CRH—chronic kidney failure	0.00073	0.000858	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CCR5—chronic kidney failure	0.00072	0.000846	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—SLC22A2—chronic kidney failure	0.000714	0.00084	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—NCF1—chronic kidney failure	0.000699	0.000821	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—NPS—chronic kidney failure	0.000692	0.000813	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—HBEGF—chronic kidney failure	0.000682	0.000802	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—F2—chronic kidney failure	0.00068	0.000799	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—DRD1—chronic kidney failure	0.000678	0.000797	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—POMC—chronic kidney failure	0.000666	0.000783	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ABCG1—chronic kidney failure	0.000664	0.000781	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CYBA—chronic kidney failure	0.000657	0.000772	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CCL2—chronic kidney failure	0.000651	0.000766	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PIP5K1B—chronic kidney failure	0.00065	0.000764	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ARG2—chronic kidney failure	0.000637	0.000749	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—LCAT—chronic kidney failure	0.000624	0.000734	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—POMC—chronic kidney failure	0.000619	0.000728	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—F2—chronic kidney failure	0.000618	0.000726	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—AVP—chronic kidney failure	0.000592	0.000696	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—HBEGF—chronic kidney failure	0.000577	0.000678	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—DDC—chronic kidney failure	0.000573	0.000674	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—EDN1—chronic kidney failure	0.000563	0.000662	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—POMC—chronic kidney failure	0.000563	0.000661	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CCL5—chronic kidney failure	0.000558	0.000657	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PRKD1—chronic kidney failure	0.000556	0.000654	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CYP2B6—chronic kidney failure	0.000556	0.000654	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PRKAG2—chronic kidney failure	0.000556	0.000654	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CCL2—chronic kidney failure	0.00055	0.000647	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—LPL—chronic kidney failure	0.000546	0.000642	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—SREBF2—chronic kidney failure	0.000521	0.000613	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—NGF—chronic kidney failure	0.000517	0.000608	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—GCKR—chronic kidney failure	0.000503	0.000592	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ABCC3—chronic kidney failure	0.000503	0.000592	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CCR5—chronic kidney failure	0.000503	0.000591	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—AVP—chronic kidney failure	0.0005	0.000588	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—LPIN1—chronic kidney failure	0.000493	0.000579	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—LRP2—chronic kidney failure	0.000483	0.000567	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CYP2C18—chronic kidney failure	0.000483	0.000567	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—EDN1—chronic kidney failure	0.000476	0.000559	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CCL5—chronic kidney failure	0.000472	0.000555	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—LPL—chronic kidney failure	0.000461	0.000543	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—NGF—chronic kidney failure	0.000437	0.000514	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—F2—chronic kidney failure	0.000432	0.000507	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CCR5—chronic kidney failure	0.000425	0.0005	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CPT1A—chronic kidney failure	0.00041	0.000482	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—IRS1—chronic kidney failure	0.000408	0.00048	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CYP2C19—chronic kidney failure	0.0004	0.00047	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—LIPC—chronic kidney failure	0.0004	0.00047	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—POMC—chronic kidney failure	0.000393	0.000462	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CCL2—chronic kidney failure	0.000385	0.000452	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—IGF1—chronic kidney failure	0.000378	0.000445	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—SCARB1—chronic kidney failure	0.000369	0.000434	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PTGS1—chronic kidney failure	0.000366	0.00043	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—F2—chronic kidney failure	0.000365	0.000429	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—SERPINE1—chronic kidney failure	0.000359	0.000422	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—SREBF1—chronic kidney failure	0.000359	0.000422	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—KRAS—chronic kidney failure	0.000356	0.000418	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—HMGCR—chronic kidney failure	0.000349	0.00041	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—IRS1—chronic kidney failure	0.000345	0.000406	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—NOS3—chronic kidney failure	0.000343	0.000403	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—FASN—chronic kidney failure	0.000341	0.000401	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—POMC—chronic kidney failure	0.000332	0.000391	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CCL2—chronic kidney failure	0.000325	0.000382	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—RELA—chronic kidney failure	0.000323	0.000379	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—IGF1—chronic kidney failure	0.00032	0.000376	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CYP3A4—chronic kidney failure	0.000316	0.000372	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ABCA1—chronic kidney failure	0.000311	0.000366	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—SERPINE1—chronic kidney failure	0.000304	0.000357	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—KRAS—chronic kidney failure	0.0003	0.000353	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—NOS3—chronic kidney failure	0.00029	0.000341	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—IL6—chronic kidney failure	0.000289	0.00034	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—RELA—chronic kidney failure	0.000273	0.000321	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—NFKB1—chronic kidney failure	0.000272	0.00032	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CAT—chronic kidney failure	0.000263	0.000309	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ABCB1—chronic kidney failure	0.000256	0.000301	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—VEGFA—chronic kidney failure	0.000247	0.00029	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—IL6—chronic kidney failure	0.000244	0.000287	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—LPL—chronic kidney failure	0.000244	0.000287	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CYP1A1—chronic kidney failure	0.000236	0.000277	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—NFKB1—chronic kidney failure	0.00023	0.00027	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—TGFB1—chronic kidney failure	0.000227	0.000267	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—MTHFR—chronic kidney failure	0.00022	0.000258	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PPARA—chronic kidney failure	0.000216	0.000253	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—KRAS—chronic kidney failure	0.00021	0.000247	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—VEGFA—chronic kidney failure	0.000209	0.000245	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—TGFB1—chronic kidney failure	0.000192	0.000225	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—KRAS—chronic kidney failure	0.000177	0.000209	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—POMC—chronic kidney failure	0.000176	0.000207	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—IL6—chronic kidney failure	0.000171	0.000201	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ALB—chronic kidney failure	0.00016	0.000188	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—NOS3—chronic kidney failure	0.000153	0.00018	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—IL6—chronic kidney failure	0.000144	0.00017	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PTGS2—chronic kidney failure	0.00014	0.000165	CbGpPWpGaD
